Last reviewed · How we verify
Adjunct Therapy to Achieve Long-term Asthma Control
Approved treatments
- Foradil · Novartis
Foradil works by stimulating the beta-2 adrenergic receptor to relax airway muscles and improve breathing. - Serevent · Fundacio Privada Mon Clinic Barcelona
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Adjunct Therapy to Achieve Long-term Asthma Control patent landscape — cliff calendar, originator estates, attackable patents
- Adjunct Therapy to Achieve Long-term Asthma Control treatment landscape brief
- Adjunct Therapy to Achieve Long-term Asthma Control treatment updates RSS
Frequently asked questions about Adjunct Therapy to Achieve Long-term Asthma Control
What drugs treat Adjunct Therapy to Achieve Long-term Asthma Control?
Tracked treatments include Foradil, Serevent.
What is the treatment for Adjunct Therapy to Achieve Long-term Asthma Control?
Standard treatment for Adjunct Therapy to Achieve Long-term Asthma Control includes Foradil, Serevent. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Adjunct Therapy to Achieve Long-term Asthma Control patent cliff · Adjunct Therapy to Achieve Long-term Asthma Control CI report
- Treatment: Foradil · Novartis
- Treatment: Serevent · Fundacio Privada Mon Clinic Barcelona
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing